+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Noven Pharmaceuticals Inc - logo

Noven Pharmaceuticals focuses on the development, manufacture and sale of prescription pharmaceutical products in the United States. The company’s products focus on women’s health, as well as central nervous system disorders, including attention deficit hyperactivity disorder (ADHD). Noven’s commercialized transdermal products include Minivelle, Daytrana and CombiPatch. The company was founded in 1987 and is based in Miami, Florida. Noven are a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co.

Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2020 - Product Thumbnail Image

Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 184 Pages
  • Global
From
HP-5000 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

HP-5000 Emerging Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
From
Noven Pharmaceuticals Inc - Strategic SWOT Analysis Review - Product Thumbnail Image

Noven Pharmaceuticals Inc - Strategic SWOT Analysis Review

  • SWOT Analysis
  • June 2023
  • 21 Pages
From
Loading Indicator